ID

20908

Beschrijving

Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B; ODM derived from: https://clinicaltrials.gov/show/NCT00412529

Link

https://clinicaltrials.gov/show/NCT00412529

Trefwoorden

Versies (1)
  1. 27-03-17 27-03-17 -
Geüploaded op

27 maart 2017

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Hepatitis B NCT00412529

Engels

Eligibility Hepatitis B NCT00412529

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
Beschrijving

Age | Chronic Hepatitis B HBeAg positive Compensated

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
UMLS CUI [2,1]
C0524909
UMLS CUI [2,2]
C0392390
UMLS CUI [2,3]
C0205432
able to comply with study regimen and provide written informed consent
Beschrijving

Protocol Compliance | Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0525058
UMLS CUI [2]
C0021430
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
pregnant or breastfeeding
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
unwilling to use double barrier method of contraception
Beschrijving

Barrier Contraception Double Unwilling

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004764
UMLS CUI [1,2]
C0205173
UMLS CUI [1,3]
C0558080
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
Beschrijving

HCV coinfection | HDV Coinfection | HIV coinfection

Datatype

boolean

Alias
UMLS CUI [1]
C1698259
UMLS CUI [2,1]
C0011220
UMLS CUI [2,2]
C0275524
UMLS CUI [3]
C4062778
received hepatitis b therapy in the past
Beschrijving

Therapeutic procedure Hepatitis B

Datatype

boolean

Alias
UMLS CUI [1,1]
C0087111
UMLS CUI [1,2]
C0019163
use of immunomodulatory therapy in past 12 months
Beschrijving

Immunomodulators

Datatype

boolean

Alias
UMLS CUI [1]
C1527392
history of or symptoms of hepatic decompensation or pancreatitis
Beschrijving

Hepatic decompensation Symptoms | Pancreatitis Symptoms

Datatype

boolean

Alias
UMLS CUI [1,1]
C1394798
UMLS CUI [1,2]
C1457887
UMLS CUI [2,1]
C0030305
UMLS CUI [2,2]
C1457887
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
Beschrijving

Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged

Datatype

boolean

Alias
UMLS CUI [1,1]
C0235378
UMLS CUI [1,2]
C0013227
UMLS CUI [1,3]
C0332183
UMLS CUI [2,1]
C0235378
UMLS CUI [2,2]
C0013227
UMLS CUI [2,3]
C0439590
UMLS CUI [3,1]
C0013227
UMLS CUI [3,2]
C1514118
UMLS CUI [3,3]
C0332183
UMLS CUI [4,1]
C0013227
UMLS CUI [4,2]
C1514118
UMLS CUI [4,3]
C0439590
concurrent medication likely to preclude compliance with schedule of evaluations
Beschrijving

Pharmaceutical Preparation Excludes Protocol Compliance

Datatype

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0525058
use of other investigational drugs within 30 days of enrollment
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
abnormal laboratory values during screening
Beschrijving

Laboratory test result abnormal

Datatype

boolean

Alias
UMLS CUI [1]
C0438215
other protocol-defined inclusion/exclusion criteria may apply
Beschrijving

Clinical Trial Eligibility Criteria Study Protocol

Datatype

boolean

Alias
UMLS CUI [1,1]
C1516637
UMLS CUI [1,2]
C2348563
Terug naar het begin van de pagina

Similar models

Eligibility Hepatitis B NCT00412529

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Age | Chronic Hepatitis B HBeAg positive Compensated
Item
male or female, 18-70 years of age with documented compensated hepatitis b "e" antigen (hbeag)-positive chronic hepatitis b
boolean
C0001779 (UMLS CUI [1])
C0524909 (UMLS CUI [2,1])
C0392390 (UMLS CUI [2,2])
C0205432 (UMLS CUI [2,3])
Protocol Compliance | Informed Consent
Item
able to comply with study regimen and provide written informed consent
boolean
C0525058 (UMLS CUI [1])
C0021430 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Pregnancy | Breast Feeding
Item
pregnant or breastfeeding
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
Barrier Contraception Double Unwilling
Item
unwilling to use double barrier method of contraception
boolean
C0004764 (UMLS CUI [1,1])
C0205173 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
HCV coinfection | HDV Coinfection | HIV coinfection
Item
co-infected with hepatitis c virus (hcv), hepatitis d virus (hdv) or human immunodeficiency virus (hiv)
boolean
C1698259 (UMLS CUI [1])
C0011220 (UMLS CUI [2,1])
C0275524 (UMLS CUI [2,2])
C4062778 (UMLS CUI [3])
Therapeutic procedure Hepatitis B
Item
received hepatitis b therapy in the past
boolean
C0087111 (UMLS CUI [1,1])
C0019163 (UMLS CUI [1,2])
Immunomodulators
Item
use of immunomodulatory therapy in past 12 months
boolean
C1527392 (UMLS CUI [1])
Hepatic decompensation Symptoms | Pancreatitis Symptoms
Item
history of or symptoms of hepatic decompensation or pancreatitis
boolean
C1394798 (UMLS CUI [1,1])
C1457887 (UMLS CUI [1,2])
C0030305 (UMLS CUI [2,1])
C1457887 (UMLS CUI [2,2])
Hepatotoxicity Pharmaceutical Preparations Frequent | Hepatotoxicity Pharmaceutical Preparations Prolonged | Pharmaceutical Preparations Nephrotoxic Frequent | Pharmaceutical Preparations Nephrotoxic Prolonged
Item
frequent or prolonged use of potentially hepatotoxic or nephrotoxic drugs
boolean
C0235378 (UMLS CUI [1,1])
C0013227 (UMLS CUI [1,2])
C0332183 (UMLS CUI [1,3])
C0235378 (UMLS CUI [2,1])
C0013227 (UMLS CUI [2,2])
C0439590 (UMLS CUI [2,3])
C0013227 (UMLS CUI [3,1])
C1514118 (UMLS CUI [3,2])
C0332183 (UMLS CUI [3,3])
C0013227 (UMLS CUI [4,1])
C1514118 (UMLS CUI [4,2])
C0439590 (UMLS CUI [4,3])
Pharmaceutical Preparation Excludes Protocol Compliance
Item
concurrent medication likely to preclude compliance with schedule of evaluations
boolean
C0013227 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0525058 (UMLS CUI [1,3])
Investigational New Drugs
Item
use of other investigational drugs within 30 days of enrollment
boolean
C0013230 (UMLS CUI [1])
Laboratory test result abnormal
Item
abnormal laboratory values during screening
boolean
C0438215 (UMLS CUI [1])
Clinical Trial Eligibility Criteria Study Protocol
Item
other protocol-defined inclusion/exclusion criteria may apply
boolean
C1516637 (UMLS CUI [1,1])
C2348563 (UMLS CUI [1,2])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial